| MCCC2 High (N=267) |
MCCC2 Low (N=268) |
P-value | |
|---|---|---|---|
| sex | |||
| FEMALE | 98 (36.7%) | 88 (32.8%) | 0.396 |
| MALE | 169 (63.3%) | 180 (67.2%) | |
| age | |||
| older | 139 (52.1%) | 129 (48.1%) | 0.411 |
| younger | 128 (47.9%) | 139 (51.9%) | |
| stage | |||
| I/II | 179 (67.0%) | 150 (56.0%) | 0.011 |
| III/IV | 88 (33.0%) | 118 (44.0%) | |
| grade | |||
| G1 | 8 (3.0%) | 6 (2.2%) | 0.165 |
| G2 | 120 (44.9%) | 111 (41.4%) | |
| G3 | 109 (40.8%) | 100 (37.3%) | |
| G4 | 28 (10.5%) | 47 (17.5%) | |
| GX | 2 (0.7%) | 4 (1.5%) | |
| T | |||
| T1/2 | 184 (68.9%) | 161 (60.1%) | 0.0408 |
| T3/4 | 83 (31.1%) | 107 (39.9%) | |
| N | |||
| N0 | 120 (44.9%) | 120 (44.8%) | 0.882 |
| N1 | 7 (2.6%) | 9 (3.4%) | |
| NX | 140 (52.4%) | 139 (51.9%) | |
| M | |||
| M0 | 218 (81.6%) | 206 (76.9%) | 0.331 |
| M1 | 33 (12.4%) | 45 (16.8%) | |
| MX | 16 (6.0%) | 17 (6.3%) | |
| pharmaceutical | |||
| NO | 242 (90.6%) | 218 (81.3%) | 0.00297 |
| YES | 25 (9.4%) | 50 (18.7%) | |
| smoking | |||
| less | 154 (57.7%) | 147 (54.9%) | 0.567 |
| more | 113 (42.3%) | 121 (45.1%) | |
| Event | |||
| 0 | 203 (76.0%) | 159 (59.3%) | <0.001 |
| 1 | 64 (24.0%) | 109 (40.7%) |